we describe our attempt to reconstitute congenitally T cell-deficient nude (nu/ nu) mice with selected Lyt spleen cell subset(s) from euthymic (nu/+) heterozygotes, and studied the immunopathology of the recipient nude mice to determine whether autoimmune disease might occur.
Materials and Methods
Mice. BALB/c nude and their heterozygous (nu/+) littermates, originally a gift from Dr. B. Kindred, Basel Institute for Immunology, Switzerland, were obtained from the Institute of Medical Science, University of Tokyo, Japan. They were bred under specific pathogen-free conditions in the Facility of Experimental Animals at Kyoto University by mating nu/nu males with nu/+ females. The age and sex of the mice used are indicated in Results. The phenotype of T cell surface antigens of BALB/c nu/+ mice is Thy-l.2, Lyt-l.2, 2.2, 3.2.
Antisera. The antisera against Thy-l.2 and Lyt antigens were prepared by standard alloimmunization using congenic mice (8) . Their titers and specificities were described previously (9) . Monoclonal antibodies (mAb) ~ anti-Lyt-l.2 ('r2a,k) [anti-Lyt-l.2(m)] (10) and anti-Lyt-2.2 (3,2a,k) [anti-Lyt-2.2(m)] (11), both from ascites, were gifts from Dr. F.-W. Shen, Memorial Sloan-Kettering Cancer Center, New York, and Dr. E. Nakayama, Center for Adult Diseases, Osaka, Japan, respectively. Their titers at 50% cytotoxicity were 1:10,000 and 1:25,000, respectively, by trypan blue dye exclusion test (12) .
Treatment of Cells With Antisera and Complement (C). Bulk treatment of cells was carried
out as previously described (9) . Briefly, 2 X l0 T spleen cells in 0.2 ml of Medium 199 (Gibco Laboratories, Grand Island, NY) with 2% fetal calf serum (FCS) (Gibco Laboratories) were incubated at 4 °C with conventional anti-Thy-1.2, Lyt-1.2, Lyt-2.2, or normal mouse serum (NMS) at final dilution of 1:7, with occasional vigorous shaking. After 40 rain, 0.75 ml of 1:6 diluted rabbit serum, selected for high C activity and low toxicity, was added. After an additional 30 min incubation at 37°C in a waterbath, the cells were washed twice with cold medium containing 5% FCS and suspended in 0.5 ml of serumfree medium, to be injected into the mice. By this protocol, the percentage of cells eliminated in a typical experiment by each antiserum and C was as follows: NMS, 12.3%, anti-Thy-l.2, 36.1%; anti-Lyt-l.2, 35.7%; and anti-Lyt-2.2, 26.7%. mAb were used at a dilution of l:10 of the original ascites.
Histological and Serological Examination. Organs or tissues (thyroid, parathyroid, lung, salivary gland, liver, stomach, small and large intestine, pancreas, kidneys, adrenal glands, spleen, lymph nodes, ovaries, epididymides, and testes) from individual mice were fixed in 10% formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (HE) for histological examination. For immunofluorescence (IF) to detect autoantibodies, various normal tissues were fixed in neutral, buffered formol saline, and embedded in alcohol-miscible wax of low melting point (37°C) (polyester wax; BDH Chemicals Ltd., Poole, Dorset, United Kingdom) (13) . Histological quality of tissue sections prepared by this method was better than that of frozen sections, and antigenicity tested by IF was comparable. After dewaxing with graded concentrations of ethyl alcohol and phosphatebuffered saline (PBS), the tissue sections were incubated for 30 min at 37°C with the mouse serum to be tested. After washing with PBS, they were treated with fluorescein isothiocyanate (FITC)-Iabeled goat anti-mouse IgG (Miles Yeda, Rehovot, Israel) diluted 1:20, incubated 30 min further at 37 °C, washed, and examined with a Zeiss photomicroscope. For the detection of thyroglobulin autoantibody, the hemagglutination test using human type O red blood cells coated with mouse thyroglobulin was used (14) . Circulating immune complexes were measured by conglutinin-binding assay with sera of old MRL/ MpJ-lpr/lpr mice as positive control (15) .
i Abbreviations used in this paper: FCS, fetal calf serum; IF, immunofluorescence; HE, hematoxylin and eosin; mAb, monoclonal antibody; NMS, normal mouse serum; PBS, phosphate-buffered saline.
Results By the C-dependent cytotoxicity test, the composition of Lyt subsets among Thy-1 +, nylon wool-nonadherent spleen cells from 3-mo-old BALB/c nu/+ mice was as follows: Lyt-1 ÷, 2,3,-(Lyt-1) cells, 40%; Lyt-1 +, 2,3 + (Lyt-1,2,3) cells, 50%; Lyt-l-, 2,3 + (Lyt-2,3) cells, negligible, if present; and Lyt-l-, 2,3-(Lyt-) cells, 5-10% (for more about Lyt-cells, see Discussion).
Induction of Oophoritis, Gastritis, and Thyroiditis in Female nu/nu Mice. Spleen cells (4 × 107) from 10-12-wk-oid female nu/+ mice were treated with various antisera plus C, then transferred intravenously, into 6-8-wk-old female nu/nu mice. Recipients were killed 3 mo later, and examined histologically and serologically for the development of autoimmune disease (Table I) . Neither NMS plus C, nor anti-Thy-1 plus C-treated cells caused any pathological alteration in the nu/nu mice. However, when the spleen cells treated with anti-Lyt-1 plus C were transferred (Table I , group C), ovaries, stomach, and/or thyroid gland of some of the recipients were destroyed, shown also in Figs. 1 and 2. Some mice developed disease in only one organ, others in more than one. Other organs and (Table l F and Table I tissues examined (see Materials and Methods) were intact, macroscopically and microscopically. We found circulating autoantibodies specific for organ components in the sera of diseased nu/nu mice by indirect IF (see Fig. 3 ). In contrast, no disease or autoantibodies appeared after transfer of nu/+ spleen cells that were treated with anti-Lyt-2 plus C (Table I , group D). The reconstitution of nu/nu mice with a mixture of cells treated with anti-Lyt-1 plus C and anti-Lyt-2 plus C, so that Lyt-l,2,3 cells were absent, also failed to cause any disease in the recipients (Table I , group E). (Table IF and Table liD After the removal of Lyt-1 ÷ cells by anti-Lyt-1 plus C treatment, Lyt-2,3 and Lyt-cells remain. To identify the cell population responsible for the induction of disease, we tried to eliminate all Lyt + cells by treating nu/+ spleen cells with a mixture of anti-Lyt-1 and anti-Lyt-2, plus C (Table IF) . This population, containing Lyt-cells but not Lyt-2,3 cells, induced disease with about the same incidence as anti-Lyt-1 plus C-treated cells. Similar treatment with anti-Lyt-1 and anti-Lyt-2 mAb, plus C, induced disease with almost the same incidence as with conventional anti-Lyt sera (Table I G) . Because treatment with mixed sera of anti-Thy-1, anti-Lyt-1, and anti-Lyt-2, plus C, completely abrogated the disease-inducing capacity of nu/+ spleen cells (Table IH) , these results, altogether, indicate that Thy-1 +, Lyt-cells were responsible for the induction of autoimmune disease.
As noted above, transferred cell populations that contained Lyt-1 cells did not cause disease, even if they also included Lyt-cells (Table I , A, D, and E). This finding was further substantiated by the transfer of Lyt-1 cells mixed with Lytcells in different ratios: when anti-Lyt-2 plus C-treated cells, which were presumed to contain Lyt-1 and Lyt-cells (prepared from 2 x 10 7 [ Table I , group I] or 1 x 10 7 [ Table I , group J] nu/+ spleen cells), were combined with Lytcells (prepared from 2 x 10 7 or 3 × 10 7 nu/+ spleen cells), and transferred to nu/nu mice, the development of all three autoimmune diseases was clearly inhibited in both groups of recipients. These results suggest that the Lyt-1 cells can suppress the ability of Lyt-cells to induce autoimmune disease.
Induction of Orchitis, Gastritis, and Thyroiditis in Male nu/nu
Mice. When a spleen cell suspension (4 x 10 7 cells) from male nu/+ mice was depleted of specific Lyt subset(s) and transferred to male nu/nu mice, some recipients of the anti-Lyt-1 plus C-treated (Table liB) or anti-Lyt-1 and anti-Lyt-2 plus C-treated cells (Table liD) developed orchitis, gastritis, and/or thyroiditis. NMS plus Cor anti-Lyt-2 plus C-treated cells did not induce disease. Figs. 1 and 2 show macroscopic and microscopic views, respectively, of affected organs from the nu/nu mice with autoimmune diseases. The ooporitic ovaries became involuted and the uterus atrophied, probably because of a deficiency of ovarian hormones (Fig. 1A) . Destruction of gastric parietal cells, which secrete hydrochloric acid, and compensatory hyperplasia of mucous cells seem to be responsible for achlorhydria and the formation of giant rugae in the cases of gastritis (Fig. 1 B) . Goiters developed in the thyroid glands of mice with thyroiditis ( Fig. 1 C) . Epididymes and testes afflicted with epididymitis and/or orchitis became involuted (Fig. 1 D) . Histologically (Fig. 2) , each disease was characterized by damage and loss of specific organ components: oocytes, gastric parietal cells, thyroid follicular cells and colloid, and sperm, accompanied by the massive infiltration of inflammatory cells, mainly mononuclear cells (for further description of histology, see legend to Fig. 2 ). Fig. 3 shows the presence of autoantibodies specific for corresponding organ components detected by indirect IF in the circulation of diseased nu/nu mice:
Histopathology of Each Autoimmune Disease and Circulating Autoantibodies Specific for Corresponding Organ Components.
Anti-zona pellucida antibody in oophoritis (some oophoritis-bearing mice also developed anti-ooplasm antibody), anti-parietal cell antibody in gastritis, anticolloid antibody in thyroiditis (which included antithyroglobulin antibody, as demonstrated by the thyroglobulin-hemagglutination test described in the legend of Fig. 4) , and antisperm antibody in epididymitis-orchitis. Titers of circulating autoantibodies in individual mice receiving anti-Lyt-1 and anti-Lyt-2 plus C-treated nu/+ spleen cells (Table IF, and Table liD) were determined by IF (Fig. 4) . In accordance with the results in Tables I and II, mice that developed histologically identified disease also had autoantibodies against corresponding organ constituents. Other Autoimmune Phenomena. Under our conditions for maintaining nu/nu mice, ~40-50% of the untreated nu/nu mice ~3 mo old developed antinuclear antibodies, assessed by IF. This has also been reported by others (16) . However, no significant increase in incidence or titer of antinuclear antibodies was observed in mice with organ-specific autoimmune disease. In addition, in none of the mice examined was Coombs' antibody present; circulating immune complex was not detected in the sera of the treated nu/nu mice, and glomerulonephritis or angitis due to immune complex desposition was not observed histologically. (Table I, C and F, and Table  II , B and D) were introduced intravenously into other nu/nu mice of the same sex as the donors. Fig. 5 shows that the histological lesion in each disease could be specifically transferred within 60 d of the initial cell inoculation, with concomitant development of circulating specific autoantibodies. Since the treatment of donor spleen cells with anti-Thy-1 and C abrogated their capacity to transfer the disease (Table III) , these results, taken together, suggest that effector T cells specific for each target organ are required for the successful transfer of these organ-specific autoimmune diseases. (Table IF and Table lID In the sera of thyroiditis-bearing mice, antithyroglobulin antibody was detected by the hemagglutination test: hemagglutinating titers were, for mice in A, × 1280, x640, and ×320; and in B, ×640 and x320, respectively.
Adoptive Transfer of Autoimmune Disease Into Other nu/nu Mice. Spleen cells (4 x 107 cells) from the disease-bearing nu/nu mice

Discussion
By dissecting splenic T cells taken from nu/+ mice into subpopulations, based on their expression of Lyt antigens, and then transferring such Lyt subsets to nu/nu mice, we were able to induce autoimmune diseases in several organs, including ovary, stomach, thyroid, and testis. These organs were damaged histologically by massive infiltration of inflammatory cells, with concomitant development of autoantibodies specific for particular components in each organ: oocytes, parietal cells, thyroid colloid (including thyrogiobUlins), and sperm. Thy-1 +, Lyt-cells were shown to be responsible for inducing disease, and Lyt-1 cells, when mixed with the Lyt-cells, were shown to have suppressive activity on the development of disease. There are some controversies concerning the expression of Lyt antigens on (Table 1, C and F, and Table II lymphocytes. Whether Lyt-1 antigens are expressed on all T cells, and even on B cells, when examined by such exquisite assays as cytofluorometry (17, 18) is, as yet, uncertain. The definition of Lyt-cells in this report is an operational one, based on a C-dependent cytotoxicity assay. We do not mean to assert that Lytcells are necessarily devoid of all Lyt antigens; their expression on Lyt-cells may be too low for lysis with antibody plus C. It may be more appropriate, therefore, to designate Thy-1 ÷, Lyt-l-, 2,3-as Thy-l~, Lyt-1J,, 2,3J,, as suggested by Shiku et al (19) . Thy-1 +, Lyt-cells detected by cytotoxicity or membrane IF assay have, thus far, been reported in normal spleen and in lymph nodes (20) , from in vitro mixed lymphocyte reactions (21), in mitogen-stimulated T blast populations (22) , from a cell line maintained by T cell growth factors (23) , in lymphoadenopathy of lupus-prone MRL mice (24) , and in the infiltrating cells in experimentally induced allergic thyroiditis (25) . Lyt-cells are also rich in peripheral blood lymphocytes of normal mice (Nakayama and Sakaguchi, unpublished data). Lytcells, prepared by C-dependent cytotoxic depletion, seem to be a distinct T cell subset as unique as other Lyt subsets. Since the adoptive transfer experiment suggested the existence of specific effector T cells for each autoimmune disease ( Fig. 5 and Table III) , Lyt-cells could be considered precursors of such effector T cells. In the cases ofautoimmune oophoritis, induced by neonatal thymectomy, (Table I F and Table II and experimental allergic thyroiditis, the autoimmune diseases can be adoptively transferred to syngeneic mice or nude mice by Lyt-1 cells alone (9), or by a Lyt-1 T cell line maintained in vitro by exogenous growth factors (26) . It is conceivable, therefore, that the Lyt-(Lyt-l~, 2,3~) population might give rise to Lyt-1 effector T cells. Since nude mice are known to have a small number of Thy-1 + cells (27) , it is also plausible that the transferred nu/+ Lyt-cells might interact with nu/nu Thy-1 ÷ cells and induce them to differentiate into effector cells.
These possibilities are now under investigation. Lyt-1 cells have been shown to have suppressive activity on cellular and humoral immunity in an antigen-specific or -nonspecific manner (28) (29) (30) . Recent investigations (31, 32) of T cell regulatory mechanisms in various immune responses have revealed suppressor circuits or cascades. These circuits involve interactions among Lyt subsets, via suppressive factors and/or antiidiotypic antibodies. The role of Lyt-1 cells as inducers (31) or first-order suppressors has received special emphasis (32) . In our experiments, Lyt-1 cells were sufficient to suppress the development of disease, apparently by acting directly upon Lytcells. Further investigation of Lyt-1 cells and their mode of action in actively regulating self-reactive clones is needed, especially to determine whether they are specific for each organ-antigen, and, if so, when and how they are sensitized to self-antigens to acquire regulatory activity. Other Lyt subsets and their interactions with Lyt-1 cells might also be involved if Lyt-cells can differentiate into other (Lyt +) subsets.
In nude mice or mice depleted of T cells (by thymectomy, irradiation, and reconstitution with bone marrow cells), no organ-specific autoimmune disease develops spontaneously under control conditions. Nor can it be induced by exogenous immunization with self-antigen such as thyroglobulin and adjuvant (33) . In the present experiment, nu/+ spleen cell suspensions freed of a particular T cell subset (i.e., Lyt-1 + cells) could induce autoimmune disease in nude mice, but those depleted of all T cells could not. Together with the necessity for T cells in adoptive transfer, these findings suggest that T cells may be required, not only for the maintenance of self-tolerance, but also for inducing autoimmunity, leading to eventual destruction of self-tissues. Without constant help from the effector T cells, B cells seem to be incapable of forming autoantibodies quantitatively or qualitatively sufficient to cause tissue damage, even if they may have the repertoire for self-constituents. This dependency has been demonstrated for human peripheral B cells binding thyroglobulin (34) ; the development of such self-reactive T cells, including helper T cells for autoantibody formation and/or T cells mediating cellular autoimmune reactions (9) , may, in turn, be checked and controlled by another T cell subset(s), in a healthy condition.
With respect to the spectrum of organs affected, and immunopathological features of individual diseases and their chronicity, the autoimmune diseases induced in the nude mice are similar to human organ-specific autoimmune diseases: Hashimoto's thyroiditis, atrophic gastritis with pernicious anemia, premature ovarian failure with antioocyte autoantibody (35) , and male infertility with antisperm autoantibody. In the human, one organ-specific autoimmune disease is frequently associated with another (36) . For organ-specific autoimmune disease to be complicated with a non-organ-specific one, such as systemic lupus erythematosus, however, is rare (37) . It is noteworthy, therefore, that even when the nude mice developed autoimmune disease on more than one organ, they did not develop non-organ-specific autoimmunity or immune complex disease, as seen in the lupus-prone NZB or MRL strains of mice (38) , or mice with chronic graft-vs.-host disease (39) . Conversely, in these models of systemic autoimmunity, few organ-specific autoimmune diseases, if any, have been reported (38, 39) . This suggests that the pathogenic mechanisms of these two groups of autoimmunities may be different.
Whether there might be some unifying element among the current theories of immunological tolerance to both self-and non-self-antigens is still in question, i.e., clonal deletion (40), T and/or B cell inactivation (41-43), or active regulation by suppressor T cells (44) . Accordingly, it is also a matter of debate whether the pathogenic mechanism of autoimmune disease can be explained by any single concept. Forbidden clones (40) , T cell bypass mechanisms (2, 43) , or defects in suppressor T cells (45) need to be thoroughly considered. Our present study strongly suggests that organ-specific autoimmune diseases can be produced by a deficit or defect in a particular T cell subset(s) that appears to have a suppressive effect on self-reactive lymphocytes. Active cellular interactions among T cell subsets, the suppressor subset being dominant in the healthy state, is presumably responsible for maintaining physiological self-tolerance to some self-constituents.
REMOVAL OF T CELL SUBSET CAUSES AUTOIMMUN1TY IN MICE
Environmental agents, infectious or toxic, may exist which selectively affect the suppressor subset to cause organ-specific autoimmune diseases. Summary Organ-specific autoimmune diseases such as oophoritis, gastritis, thyroiditis, and orchitis were induced in female or male nude (nu/nu) mice by the transfer ofnu/+ spleen cells from which particular Lyt T cell subset(s) had been removed: nu/+ spleen cells treated with anti-Lyt-1 plus complement (C) caused disease in recipient nude mice; anti-Lyt-2 plus C-treated spleen cells, in contrast, did not. The cells responsible for disease induction are believed to be Thy-1 +, Lyt-l-, 2,3-(Thy-l~', Lyt-l~, 2,3~), since spleen cells treated with mixed antisera, including anti-Lyt-1 and anti-Lyt-2, plus C, could induce the disease with almost the same incidence as anti-Lyt-1 plus C-treated cells (oophoritis 50%, gastritis 25%, thyroiditis 10-20%, and orchitis 40%). Cells treated with mixed antisera of anti-Thy-1, anti-Lyt-1, and anti-Lyt-2, plus C, could not induce autoimmune disease.
Each induced autoimmune disease could be adoptively transferred to other nude mice via spleen cells, with resulting histological lesion of corresponding organs and development of specific circulating autoantibodies. Since anti-Thy-1 plus C treatment of donor spleen cells abrogated the capacity to transfer the disease, we conclude that T cells are required as effector cells, and that these may develop from Lyt-l-, 2,3-cells.
Lyt-1 +, 2,3-cells were demonstrated to have suppressive activity upon the development of the diseases; induction of autoimmunity was completely inhibited by the cotransfer of Lyt-1 +, 2,3-cells with Lyt-l-, 2,3-cells. When anti-Lyt-2 plus C-treated cells (i.e., Lyt-1 +, 2,3-and Lyt-l-, 2,3-cells) were mixed with anti-Lyt-1 and anti-Lyt-2 plus C-treated cells (i.e., Lyt-l-, 2,3-cells) in various ratios, then transferred to nude mice, the development of each autoimmune disease was clearly inhibited, even by small doses of Lyt-1 +, 2,3-cells.
The autoimmune disease we were able to induce was quite similar to human organ-specific autoimmune disease in terms of the spectrum of organs involved, histopathological features, and the development of autoantibodies to corresponding organ components (oocytes, parietal cells, thyroid colloid, including thyroglobulin, and sperm). The results offer direct evidence for the active participation of T cells in natural self-tolerance to certain self-constituents, and suggest that a deficit or defect in certain T cell subset(s) is a possible cause of organ-specific autoimmune disease in humans.
